This 2013 edition of MSAA’s MS Research Update is the first to be printed as a stand-alone issue, reflecting the diversity and scope of research progress in MS. This information is based on a wide range of sources, including the extensive journal literature on MS and its management, a review of ongoing clinical trials, and papers presented at major national and international conferences.
Included in the online issue:
* Cover Story – The Evolution of MS Diagnosis, Treatment, and Care
* Research News – Aubagio® approval and other research updates
* Health and Wellness – The benefits of aquatic therapy and exercise
…Plus, extra “Ask the Doctor” answers, not included in the printed magazine!
The Evolution of MS Diagnosis, Treatment, and Care:
From the mid-1800s to the late 1900s, diagnostic criteria and therapies were fraught with uncertainty – and required more than a century of trial and error to reach today’s high level of success. Seventeen MS specialists are quoted, giving details about the most important contributions in MS history.
Read about the recent FDA-approval of Aubagio® (teriflunomide), as well as updates on DMF (dimethyl fumarate) and Lemtrada™ (alemtuzumab), both submitted for FDA approval.
Health and Wellness:
Aquatic therapy and aquatic exercise are described, along with the benefits that they offer to individuals with MS.
The Motivator is MSAA’s award-winning magazine provided to the MS community and to our generous supporters.